<DOC>
	<DOC>NCT00119743</DOC>
	<brief_summary>The purpose of this study is to assess the efficacy in young children in preventing acute otitis media due to vaccine serotype pneumococcal or non typable Hemophilus influenza, following immunization with an 11-valent pneumococcal vaccine according to a 3 dose primary vaccination in the first year of life, with booster dose in the second year of life. Prophylactic immunization with pneumococcal conjugate vaccine is compared to placebo (hepatitis A vaccine).</brief_summary>
	<brief_title>A Efficacy Against Otitis Media in Children With 11 Valent Pneumococcal Vaccine</brief_title>
	<detailed_description />
	<mesh_term>Otitis Media</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Male or female between 6 weeks and 5 months (42152 days) of age at the time of first vaccination. Use of any investigational or nonregistered drug or vaccine other than the study vaccine(s) within 30 days preceding the first dose of study vaccine, or planned use during the study period.</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>27 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prophylaxis pneumococcal vaccine</keyword>
</DOC>